Actual Medicinal Product (AMP) Acrivastine 8mg capsules (Medihealth (Northern) Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Benadryl Allergy Relief 8mg capsules (McNeil Products Ltd).

Generic
Acrivastine
Formulation
Acrivastine 8mg capsules
  • Acrivastine
    • Acrivastine 8mg capsules

      • Acrivastine 8mg capsules (Medihealth (Northern) Ltd)



Related Formulations (1)

compatible logo Acrivastine 8mg capsules